Q1 2018 Cesca Therapeutics Inc Earnings Call
שיחת ועידה Cesca Therapeutics Inc
Cesca Therapeutics Inc Conference call will be held on 14/05/2018. During the earnings conference call's session Cesca Therapeutics Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Cesca Therapeutics Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
Cesca Therapeutics Inc. ("Cesca Therapeutics", "Cesca", the "Company", "we", "our", "us"), formerly known as ThermoGenesis Corp, is focused on the research, development, and commercialization of autologous cell-based therapies that advance the practice of regenerative medicine. The Company was founded in 1986 as ThermoGenesis Corp., a Delaware corporation, with principal offices in Rancho Cordova, California. It is an established leader in the development and manufacture of automated blood and bone marrow processing systems that enable the separation, processing and cryopreservation of cell and tissue therapy products, serving patients, physicians and partners in three target markets: * Cellular Therapeutics * Medical/Diagnostic Device Development and Commercialization * Cell Manufacturing and Banking. On February 18, 2014, TotipotentRX Corporation ("TotipotentRX", "Totipotent" or "TRX"), merged with and into ThermoGenesis Corp ("ThermoGenesis").קרא עוד שיחת ועידה